Is neoadjuvant chemoradiotherapy for pancreatic cancer beneficial: A systematic review and meta-analysis.

Front Oncol · 2022 · PMC9727153 · PMID 36505795

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In this meta-analysis, we identified a significant trend toward improved 2-year OS in the neoadjuvant CRT groups than the upfront surgery group.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.